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Enables Imaging of Transplanted Cardiac Stem Cells
In Vivo by Single-Photon Emission Computed
Tomography or Positron Emission Tomography
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Junichiro Miake, MD, PHD,* Michelle K. Leppo, BS,* James Fox, BS,† Jurgen Seidel, PHD,†
Martin Pomper, MD, PHD,§ Richard L. Wahl, MD,‡ Benjamin Tsui, PHD,† Frank Bengel, MD,‡
Eduardo Marba´n, MD, PHD,* M. Roselle Abraham, MD*
Baltimore, Maryland
Objectives We examined the sodium-iodide symporter (NIS), which promotes in vivo cellular uptake of technetium 99m
(99mTc) or iodine 124 (124I), as a reporter gene for cell tracking by single-photon emission computed tomography
(SPECT) or positron emission tomography (PET) imaging.
Background Stem cells offer the promise of cardiac repair. Stem cell labeling is a prerequisite to tracking cell fate in vivo.
Methods The human NIS complementary deoxyribonucleic acid was transduced into rat cardiac-derived stem cells (rCDCs) us-
ing lentiviral vectors. Rats were injected intramyocardially with up to 4 million NIS-rCDCs immediately after left ante-
rior descending coronary artery ligation. Dual isotope SPECT (or PET) imaging was performed, using 99mTc (or 124I) for
cell detection and thallium 201 (or ammonia 13) for myocardial delineation. In a subset of animals, high resolution
ex vivo SPECT scans of explanted hearts were obtained to confirm that in vivo signals were derived from the cell injec-
tion site.
Results NIS expression in rCDCs did not affect cell viability and proliferation. NIS activity was verified in isolated
transduced cells by measuring 99mTc uptake. NIS rCDCs were visualized in vivo as regions of 99mTc or
124I uptake within a perfusion deficit in the SPECT and PET images, respectively. Cells could be visualized
by SPECT up to 6 days post-injection. Ex vivo SPECT confirmed that in vivo 99mTc signals were localized to
the cell injection sites.
Conclusions Ectopic NIS expression allows noninvasive in vivo stem cell tracking in the myocardium, using either SPECT or
PET. The general approach shows significant promise in tracking the fate of transplanted cells participating
in cardiac regeneration, given its ability to observe living cells using clinically applicable imaging modalities.
(J Am Coll Cardiol 2008;52:1652–60) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.06.051d
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ntem cells offer the promise of organ repair on demand. Our
re-clinical studies, and studies by other groups, in small
nd large animal models indicate that autologous cardiac-
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y a grant from the German Research Foundation (DFG, grant BA 3341/1-1). Drs.
errovitis and Marban are currently affiliated with The Heart Institute, Cedars Sinai
edical Center, Los Angeles, California.s
Manuscript received February 26, 2008; revised manuscript received May 7, 2008,
ccepted June 19, 2008.erived stem cells (CDCs) can successfully regenerate myo-
ardium in the setting of ischemic damage (1–4). Despite
his initial success, an important problem that remains to be
ackled is low levels of transplanted cell survival and engraft-
ent (5–7). In vivo stem cell tracking is a prerequisite to
See page 1661
nderstanding stem cell biology, optimizing engraftment,
nd maximizing the functional benefits of stem cell therapy
n the heart (8). The ideal cell-tracking method should be
ontoxic, sensitive, and specific for the labeled cells, and
hould permit long-term follow-up (9).
a
(
r
n
a
a
o
s
(
o
d
p
e
(
t
d
r
p
w
i
q
M
C
t
(
A
m
a
m
d
L
t
t
d
p
o
(
C
p
v
a
(
p
p
N
P
(
m
(
w
m
l
I
P
m
M
(
C
p
b
h
g
b
t
T
1
2
j
r
C
r
t
w
w
1
g
w
i
h
9
i
D
O
m
o
a
S
P
i
C
a
a
A
t
s
o
p
b
s
l
s
T
O
(
v
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November 11, 2008:1652–60 Stem Cell Tracking by SPECT and PETMost studies have used direct labeling of stem cells with
gents such as radionuclides or particles before transplantation
8,9). In this study, we adopted a novel approach of using a
eporter gene (the sodium-iodide symporter [NIS]) that is
ormally expressed in the thyroid, stomach, choroids plexus,
nd salivary gland (10), but not in the heart, to track CDCs
fter injection into the heart; the NIS promotes cellular uptake
f iodide or pertechnetate (technetium 99m [99mTc]) and
odium ions, driven by the transmembrane sodium gradient
11). Remarkably, after ectopic NIS expression, only cells
verexpressing NIS will uptake 99mTc (pertechnetate) or io-
ine 124 (124I) after intravenous injection of these tracers,
ermitting noninvasive, longitudinal monitoring of stem cell
ngraftment by single-photon emission computed tomography
SPECT) and positron emission tomography (PET), respec-
ively. The main advantage of the reporter gene approach over
irect stem cell labeling approaches is that expression of the
eporter gene and functional competence of the expressed
rotein are dependent on cell viability, unlike direct labeling
here the label can be taken up by cardiac myocytes or
nflammatory cells after labeled cell death, thus confounding
uantification of engraftment (12–14).
ethods
ells. Rat cardiac-derived stem cells (rCDCs) were cul-
ured from Wistar Kyoto rats as previously described (1,2)
Online Methods).
nimal model. Wistar Kyoto rats (n  31) underwent
yocardial infarction by permanent ligation of the left
nterior descending coronary artery, after which 1 to 4
illion NIS syngeneic rCDCs were injected intramyocar-
ially at 2 to 4 sites (Online Appendix).
entivirus preparation. A third-generation lentiviral vec-
or system was used to label the rCDCs (15). Expression of
he human sodium-iodide symporter (hNIS) gene was
riven by constitutively active promoters, cytomegalovirus
romoter (CMV) or CAG (composite promoter consisting
f the CMV enhancer and chicken beta actin promoter)
Online Appendix).
ell proliferation. A colorimetric proliferation assay was
erformed to test the effect of ectopic NIS expression on CDC
iability/function (Online Appendix). In vitro angiogenesis
ssays were performed as recommended by the manufacturer
Becton-Dickinson, Franklin Lakes, New Jersey) (Online Ap-
endix). In vitro 99mTc (pertechnetate) uptake assay was
erformed to examine the function of the ectopically expressed
IS (Online Appendix).
olymerase chain reaction (PCR). Reverse transcription
RT)-PCR was performed to confirm NIS expression in
yocardium, 24 h after injection of NIS-labeled rCDCs
Online Appendix). Quantitative PCR for the rat SRY gene
as performed on days 1 and 8 to confirm CDC engraft-
ent after gender-mismatched rCDC transplantation (On-ine Appendix). an vivo imaging. S PECT/COM-
UTED TOMOGRAPHY (CT). Ani-
als were imaged using a Gamma
edica X-SPECT-CT scanner
Gamma Medica, Northridge,
alifornia). SPECT imaging was
erformed before PET imaging
ecause 124I has a relatively long
alf-life (4.2 days) and emits
amma rays that would increase
ackground and decrease con-
rast during SPECT imaging.
he radioisotopes 99mTc (7.7 
.7 mCi/285  63 MBq) and
10Tl (1 mCi/37 MBq) were in-
ected via the tail vein (n  13; 6
eceived CMV.NIS cells, 5
AG.NIS, and 2 nontransduced
CDCs), 24 h after CDC injec-
ion. In addition, 3 rats injected
ith 4  106 CMV.NIS cells
ere imaged on days 1, 3, 6, and
0 post-transplantation for lon-
itudinal cell tracking. Images
ere acquired 1 h after tracer
njection, since this time point
as been associated with peak myocardial accumulation of
9mTc in a previous detailed time course study (16). Dual
sotope SPECT was performed to shorten scan time.
etails regarding the imaging protocol are provided in the
nline Methods. Resolution of the SPECT system was 1.7
m (full width at half maximum), at the center of the field
f view (with a radius of rotation of 5 cm and a pinhole
perture of 1 mm). X-ray CT was performed on the same
PECT/CT system (Online Appendix).
ET/CT. 124I (3.70  1.45 mCi/137  54 MBq) was
njected via the tail vein (n  5; 3 received CAG.NIS
DCs and 2 CMV.NIS CDCs) 24 h after SPECT imaging
nd 48 h after CDC transplantation. A static 30-min
cquisition was obtained 1 h after tracer injection.
mmonia-13 1 mCi (37 MBq) was injected after comple-
ion of the iodine acquisition, and was followed by a 20-min
tatic acquisition. Since the ammonia scan was intended
nly for myocardial delineation and not for quantification of
erfusion, the high background from persisting 124I in the
lood pool was not of concern, although it could have
lightly diminished the contrast between myocardium and
eft ventricular (LV) cavity.
The PET images were acquired on a small animal PET
ystem (VISTA, GE Healthcare, Piscataway, New Jersey).
he complete PET imaging protocol is described in the
nline Appendix. Resolution of the system was 1.4 mm
full width at half maximum) at the center of the field of
iew (17). Images after each tracer administration were
Abbreviations
and Acronyms
CDC  cardiac-derived
stem cell
CMV  cytomegalovirus
promoter
CR  contrast ratio
CT  computed
tomography
LV  left
ventricle/ventricular
MRI  magnetic resonance
imaging
NIS  sodium-iodide
symporter
PET  positron emission
tomography
rCDC  rat cardiac-derived
stem cell
RT-PCR  reverse
transcription-polymerase
chain reaction
SPECT  single-photon
emission computed
tomographycquired at exactly the same position. Coregistration of
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Stem Cell Tracking by SPECT and PET November 11, 2008:1652–60ET and CT images was performed using rigid body
ransformation and is described in the Online Methods
Online Fig. 1).
x vivo SPECT imaging. To validate the results obtained
y in vivo imaging and to confirm the origin of the in vivo
ignal, a high resolution ex vivo SPECT scan was performed
n  5) after the completion of the in vivo experiment
Online Appendix).
mage analysis. All images were analyzed using AMIDE
oftware (18). A volume of interest was drawn to include the
right spot at the cell injection site, for each animal. The
ame volume of interest was then placed inside the LV
avity to obtain signal intensities in the blood pool. Contrast
atio % was defined as: 100 ([signal in the cells] [signal
n blood pool])/signal in blood pool. A detailed description
f the signal quantification protocol we employed is pro-
ided in the Online Methods.
tatistical analysis. Values are reported as mean  SD.
epeated measures analysis of variance was used for com-
arison of cell proliferation rates (NIS vs. nontransduced
DCs) at different time points. The paired t test was used
o compare contrast ratio (CR) between SPECT and PET
mages and percent uptake of injected dose between
PECT images. Statistical analysis was performed using
raph Pad Prism software, version 4 (Graph Pad Software,
a Jolla, California). A value of p  0.05 was chosen for
tatistical significance.
esults
mmunostaining and RT-PCR. Ectopic expression of
NIS in transduced rCDCs was confirmed by immuno-
taining with a human-specific NIS antibody (Fig. 1A).
n addition, expression of hNIS messenger ribonucleic acid
Figure 1 Confirmation of hNIS-Expression
(A) Immunostaining confirmed the expression of human sodium-iodide symporter (
counterstained by blue Hoechst dye). (B) hNIS messenger ribonucleic acid was de
tation of sodium-iodide symporter (NIS) rat cardiac-derived stem cells (band at 35
cific band in a rat heart injected with the same number of NIS cells. (C) Confirma
99m (pertechnetate) uptake by NIS rat cardiac-derived stem cells; this uptake wa
dent experiments, each condition tested in triplicate). ctr  control.as detected by amplification of a 353-bp band using gene apecific primers for RT-PCR on messenger ribonucleic acid
solated from hearts of animals injected with NIS rCDCs.
n vitro 99mTc (pertechnetate) uptake. Functionally,
IS cells accumulated 99mTc (pertechnetate), an effect
hat was inhibited by the specific NIS blocker, sodium
erchlorate (uptake: 6.0  0.9% vs. 0.07  0.05%, without
nd with blocker, respectively) (Fig. 1C); nontransduced
ells did not demonstrate any 99mTc uptake. We attribute
he low in vitro uptake of 99mTc to rapid tracer efflux from
he transduced cells (19,20). We believe that this property
ould be favorable for the use of NIS as a reporter gene,
ince the transient intracellular presence of the radiotracer
ould reduce the risk of radiotoxicity to the stem cells (20).
ell viability and function. Overexpression of hNIS did
ot significantly affect rCDC viability or proliferation, when
ompared with that of nontransduced control cells (p 
.718 by repeated measures analysis of variance) (Fig. 2A).
ikewise, cells overexpressing hNIS did not demonstrate
ny decrease in their cardiogenic potential, determined by
dditional transduction of cells with a lentiviral construct
xpressing firefly luciferase under transcriptional control of a
ardiac-specific promoter (NCX1 or cardiac sodium-
alcium exchanger) (Fig. 2B) (21) or in their angiogenic
apacity (determined by their ability to form vascular tubes
n an angiogenesis assay) (Figs. 2C to 2E).
n vivo SPECT. Thalium 201 perfusion scans lead to
dequate visualization of the viable myocardium in all
xperiments. A large perfusion deficit due to infarction was
een in the middle and apical segments of the anterior and
nterolateral walls and septum. Cells expressing hNIS were
dentified as a region of increased tracer uptake within the
erfusion deficit area (Figs. 3A to 3C), in all animals on day
post-transplantation (11 of 11, 2 injected with 106 cells
(green) in rat cardiac-derived stem cells after lentiviral transduction (nuclei were
by reverse transcription-polymerase chain reaction in rat hearts after transplan-
e pairs [bp] white arrow, I). The white arrow for II indicates the lack of a spe-
f hNIS activity in transduced cells. NIS transduction promoted in vitro technetium
lished by the specific NIS blocker sodium perchlorate (100 mol/l) (2 indepen-hNIS)
tected
3 bas
tion o
s abond 9 with 2  106 cells), whereas, in animals that received
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November 11, 2008:1652–60 Stem Cell Tracking by SPECT and PETontrol, nontransduced CDCs (n  2, 1 injected with 106
ells and 1 with 2  106 cells), the only cardiac 99mTc
pertechnetate) signal was derived from the blood pool
Figs. 4A to 4C). 99mTc (pertechnetate) uptake of the hNIS
ells (% of injected dose) was 0.08  0.07% (n  11);
Figure 2 Effect of hNIS Overexpression on Cell Viability, Prolife
(A) There was no difference in viability and proliferation of NIS versus nontransd
struct expressing firefly luciferase under the transcriptional control of a cardiac-spe
cardiogenic potential of hNIS-expressing cells compared with control cells. (C to E
vascular endothelial cells as positive control cells (C), nontransduced rat cardiac-d
The ability to form vascular structures was preserved after transduction with hNIS.
Figure 3 Dual Isotope SPECT/CT of an Animal Injected With hN
(Red) Technetium 99m uptake; (green) thallium 201 (201Tl) uptake. There is a cle
stem cell injection site within a perfusion deficit. Noninfarcted myocardium appear
(A) Transverse, (B) coronal, and (C) sagittal slice orientation. CT  computed tom
computed tomography.nimals injected with CMV.NIS transduced cells had a
ignificantly higher pertechnetate uptake than animals in-
ected with CAG.NIS transduced cells (0.12  0.07% vs.
.03  0.03%, p  0.027), in concordance with our in vitro
ata comparing the 2 promoters, using firefly luciferase as
n, and Function
at cardiac-derived stem cells. (B) Additional transduction with a lentiviral con-
romoter (NCX1, cardiac sodium-calcium exchanger) indicated no decrease in the
genesis and vascular tube formation assays. Representative images of human
stem cells (D), and rat cardiac-derived stem cells transduced with hNIS (E).
viations as in Figure 1.
xpressing Cells
amyocardial region (yellow arrows) corresponding to the rat cardiac-derived
n due to 201Tl uptake. The liver was also visualized due to uptake of 201Tl.
hy; hNIS  human sodium-iodide symporter; SPECT  single-photon emissionratio
uced r
cific p
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Stem Cell Tracking by SPECT and PET November 11, 2008:1652–60he reporter gene (Online Appendix, Online Fig. 2). The
R was also higher when CDCs transduced with CMV.NIS
ere used (70 40% with CMV.NIS cells vs. 28 29% for
AG.NIS cells, p  0.085), indicating higher expression
evels of NIS in CMV.NIS cells and consequently higher
ertechnetate uptake. These results underscore the impor-
ance of the promoter and consequently transgene expres-
ion levels on the outcome of in vivo imaging. Importantly,
R between injection site and myocardium and lung was
igh (115 49% and 202 121%, respectively), indicating
ack of specific uptake of pertechnetate by tissues that do not
ormally express NIS. In fact, CR between the region of the
yocardium containing the perfusion deficit (corresponding
o the injection site) and the LV cavity was 18  10% in
he animals injected with nontransduced cells; this indicates
brighter signal in the blood pool than in the hypoperfused
nfarcted myocardium.
In animals (n  3) injected with 4  106 CDCs that
nderwent serial SPECT imaging, CDCs were identified
n day 1, 3, and 6 post-injection (CR was 452  29%,
96  71%, and 131  66%, on days 1, 3, and 6,
espectively) (Fig. 5), but not on day 10, where the CR
as 1.1  14%, between the area of brightest signal in
he myocardium and the LV cavity. These results indicate
hat NIS can be used for longitudinal stem cell tracking
fter transplantation.
n vivo PET. Ammonia 13 perfusion scans generated clear
mages of the viable myocardium in 5 of 5 animals that
nderwent small animal PET. All animals received 2  106
ells (2 received CAG.NIS and 3 CMV.NIS cells). Injection
ites were identified in 3 of 5 animals (2 had received
MV.NIS and 1 CAG.NIS cells) (Figs. 6D to 6F and 7A to
C). CR obtained by PET was low (18 8%) in this particular
xperimental setting (dedicated small animal scanner and 124I
s tracer), suggesting limitations of 124I as a positron emitting
racer. Coregistration of the PET images with CT confirmed
ignal localization in myocardium (Fig. 7).
x vivo SPECT. An ex vivo cardiac SPECT scan was
erformed in 5 animals after the completion of in vivo
Figure 4 Dual Isotope SPECT/CT of an Animal Injected With N
(Red) Technetium 99m uptake; (green) thallium 201 uptake. The only Tc signal in
pool (atrial and ventricular cavities). (A) Transverse, (B) coronal, and (C) sagittalmaging in order to verify that signal was indeed from cells snd not from the blood pool. A region of increased 99mTc
pertechnetate) uptake that was similar in appearance to the
n vivo signal was identified within the myocardium, but the
R was considerably higher (323  293% vs. 70  40%)
ue to lack of signal from the blood pool (Online Fig. 3).
T-PCR. Quantitative PCR confirmed that rapid cell loss
ccurred within the first week after intramyocardial CDC
mplantation. We found that 13.2  3.6% of the injected
ells were retained on day 1, and 2.8  1.8% on day 8 after
ransplantation (Fig. 8). Based on these PCR results, we
stimate that the threshold for CDC detection by SPECT
s approximately 150,000 cells.
iscussion
racking stem cell fate after transplantation is essential for
lucidation of the mechanisms underlying stem cell engraft-
ent and resultant functional benefit. This is the first report
sing hNIS as the reporter gene to track stem cells in the
eart by SPECT and PET imaging. The advantages of this
pproach are that it is translatable into the clinical setting
ecause it employs a transgene that is nonimmunogenic and
he radiotracer 99mTc with SPECT scanning, both of which
re widely available and Food and Drug Administration–
pproved.
To date, most cell-tracking studies have used in vitro cell
abeling with iron nanoparticles followed by in vivo mag-
etic resonance imaging (MRI) (22–24). Despite the sig-
ificant advantages of MRI (high sensitivity, excellent
natomical and functional data), we and others recently
howed that iron-derived signals can persist in the myocar-
ium and can be detected by MRI long after cells have been
estroyed, generating false-positive signals (12–14). Genetic
abeling, however, offers the important advantage that only
ells expressing the transgene will generate a signal (25,26).
Further significance of the present study lies in its
otential for clinical translation. Pertechnetate SPECT is a
idely available, clinically approved, relatively low cost
maging modality. Results obtained by SPECT imaging in
nsduced Cells
ardiac region is derived from the blood
rientation. Abbreviations as in Figure 3.ontra
the c
slice omall animals can be easily tested in larger animal models or
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November 11, 2008:1652–60 Stem Cell Tracking by SPECT and PETumans, using clinical SPECT systems. Importantly, there
as been substantial progress in absolute signal quantifica-
ion in clinical SPECT systems in recent years, a fact that
trengthens even further the role of SPECT for in vivo stem
ell tracking (27).
The wild-type or mutated herpes virus thymidine kinase
ene is another transgene that has been successfully used for
tem cell tracking by SPECT or PET imaging. hNIS has 2
mportant advantages over herpes virus thymidine kinase: it
tilizes widely available tracers, so no specialized radio-
ynthesis facilities are needed, and it is a human gene,
recluding an immune response if applied clinically.
To date, only direct labeling of stem cells by 111Indium-
xine or 99mTc hexamethylpropylenamine oxime (Tc-
MPAO) has been used for stem cell tracking by SPECT
28,29). These techniques only permit stem cell tracking
Figure 5 Longitudinal Tracking of hNIS-Expressing Cell by SPEC
(Upper panel) Day 1 after cell injection; (middle panel) day 3 after cell injection; (
Arrows point to signal from engrafted cells. Display settings are identical in all imver a short period of time, determined by the tracer falf-lives (2.8 days for indium and 5.8 h for 99mTc), and also
ose the risk of radiotoxicity to the cells. In the present
tudy, we showed that hNIS expression in CDCs is non-
oxic and can promote adequate tracer uptake to allow
n-vivo cell imaging. Even in short-term studies, visualizing
ells using a reporter gene approach is superior to any direct
abeling method, since signal in the former is always derived
rom viable transplanted cells (high specificity). With direct
abeling, a fraction of the signal might be derived from
racer released by dead cells and persisting at the injection
ite (in the extracellular space or uptaken by other cell
ypes), generating false positives and undermining the
iological interpretation of the in-vivo imaging studies.
Despite the widespread availability of SPECT, PET is
ttractive for stem cell studies because it is more sensitive
nd the signal is readily quantifiable. Here, we showed the
panel) day 6 after cell injection.
bbreviations as in Figure 3.T
lower
ages. Aeasibility of tracking CDCs in the myocardium by PET,
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Stem Cell Tracking by SPECT and PET November 11, 2008:1652–60sing hNIS as reporter gene. However, the contrast
chieved was suboptimal when compared with our SPECT
esults. Possible explanations for this unexpected finding
nclude: 1) 124I is not a pure positron emitter; only 25.6% of
he activity is emitted as positrons, resulting in significantly
ower efficiency for this agent as a PET tracer; 2) the
Figure 6 SPECT and PET Imaging of an Animal Injected With h
(A to C) SPECT/computed tomography 24 h after cell injection. Red: technetium 9
expressing rat cardiac-derived stem cells. (A) Transverse, (B) coronal, and (C) sa
Red: iodine 124 uptake; green: ammonia 13 uptake. White arrows point to signa
tion. PET  positron emission tomography; other abbreviations as in Figure 3.
Figure 7 Successful PET/CT Coregistration Based on the 18Flu
Red: iodine 124 (124I) uptake. White arrows point to signal from hNIS-expressing
image (yellow arrows). Noninfarcted myocardium and liver (black arrows) take up
and (C) sagittal slice orientation. CT  computed tomography; other abbreviationsmission of coincident, high-energy gamma rays signifi-
antly increases scatter and background activity, leading to
onsiderable image deterioration; and 3) positrons emitted
y 124I annihilate at a relatively long distance (approximately
.4 mm in comparison to 0.2 mm for positrons emitted by
8F) in relation to their site of production, leading to
xpressing Cells
take; green: thalium 201 uptake. White arrows point to signal from hNIS
lice orientation. (D to F) PET of the same animal at 48 h after cell injection.
hNIS-expressing cells. (D) Transverse, (E) coronal, and (F) sagittal slice orienta-
PET Images
diac-derived stem cells. The stomach takes up 124I and is visualized in the
nia 13 and appear green in the perfusion scan. (A) Transverse, (B) coronal,
Figures 3 and 6.NIS-E
9m up
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November 11, 2008:1652–60 Stem Cell Tracking by SPECT and PETegradation of spatial resolution (30). This adverse charac-
eristic is of greater importance in small animal studies,
here small errors in localization are large in relation to the
ize of the myocardium. Despite the disadvantages, there
s potential for improvement: the positron emitter 94mTc-
ertechnetate can be used instead of 124I for clinical
ranslation; although 94mTc is not a pure positron emit-
er, it has a more attractive half-life (52.5 min instead of
.2 days for 124I) and does not affect thyroid gland
unction.
Several limitations have to be acknowledged. The present
roof-of-concept study was confined to assessment of CDC
ngraftment, not functional effects of transplantation, in a
mall animal model; feasibility in a large animal model
eeds to be demonstrated before definitive conclusions
bout clinical translatability can be drawn. However, appli-
ation in larger animals is expected to be less challenging,
ince a considerably higher number of cells will be injected,
esulting in higher tracer uptake and stronger in vivo signals.
Another fact that limits immediate translation of our
esults into patients is the use of lentivirus vectors that
ave not yet been approved for human use due to safety
oncerns. This is not an inherent feature of the method;
outine plasmid transfection followed by cytotoxic selection
ould equally well be used to establish NIS-expressing cell
ines.
onclusions
his is the first report of in vivo CDC tracking by
PECT and PET, using the sodium-iodide symporter as
he reporter gene. This technique is readily translatable
nto the clinical realm and could be expected to improve
ur understanding of in vivo stem cell biology and eventu-
lly the functional effects of stem cell transplantation in the
Figure 8 CDC Engraftment by Quantitative PCR
Column histogram reveals percentage cell engraftment on days 1 and 8 rela-
tive to baseline. Rapid cell loss occurs within 8 days after intramyocardial cell
delivery. CDC  cardiac-derived stem cell; PCR  polymerase chain reaction.eart.eprint requests and correspondence: Dr. M. Roselle Abraham,
epartment of Medicine, 720 Rutland Avenue, Ross 844, Balti-
ore, Maryland 21205. E-mail: mabraha3@jhmi.edu.
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